⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRC News
SciSparc Ltd. Ordinary Shares
SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
globenewswire.com
SPRC
SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery
globenewswire.com
SPRC
SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio
globenewswire.com
SPRC
SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors
globenewswire.com
SPRC
SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
globenewswire.com
SPRC
SciSparc Resolves to Launch Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery
globenewswire.com
SPRC